Bank of America’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.63M Buy
265,117
+68,315
+35% +$936K ﹤0.01% 3568
2025
Q1
$2.18M Buy
196,802
+124,330
+172% +$1.38M ﹤0.01% 3862
2024
Q4
$772K Buy
72,472
+5,983
+9% +$63.7K ﹤0.01% 4435
2024
Q3
$844K Buy
66,489
+403
+0.6% +$5.12K ﹤0.01% 4378
2024
Q2
$1.11M Buy
66,086
+13,023
+25% +$219K ﹤0.01% 4128
2024
Q1
$796K Sell
53,063
-18,601
-26% -$279K ﹤0.01% 4296
2023
Q4
$1.07M Buy
71,664
+28,326
+65% +$425K ﹤0.01% 4092
2023
Q3
$607K Buy
43,338
+11,759
+37% +$165K ﹤0.01% 4371
2023
Q2
$327K Sell
31,579
-99,036
-76% -$1.03M ﹤0.01% 4723
2023
Q1
$1.21M Buy
130,615
+10,139
+8% +$93.7K ﹤0.01% 4084
2022
Q4
$1.07M Buy
120,476
+404
+0.3% +$3.58K ﹤0.01% 4160
2022
Q3
$999K Sell
120,072
-3,535
-3% -$29.4K ﹤0.01% 4190
2022
Q2
$1.01M Sell
123,607
-4,710
-4% -$38.6K ﹤0.01% 4238
2022
Q1
$1.12M Buy
128,317
+87,055
+211% +$758K ﹤0.01% 4469
2021
Q4
$392K Buy
41,262
+4,719
+13% +$44.8K ﹤0.01% 5278
2021
Q3
$614K Sell
36,543
-53,092
-59% -$892K ﹤0.01% 4708
2021
Q2
$1.37M Buy
89,635
+56,313
+169% +$860K ﹤0.01% 4009
2021
Q1
$650K Sell
33,322
-864
-3% -$16.9K ﹤0.01% 4571
2020
Q4
$616K Buy
34,186
+21,227
+164% +$382K ﹤0.01% 4185
2020
Q3
$250K Sell
12,959
-706
-5% -$13.6K ﹤0.01% 4571
2020
Q2
$357K Buy
13,665
+895
+7% +$23.4K ﹤0.01% 4346
2020
Q1
$228K Buy
12,770
+3,871
+43% +$69.1K ﹤0.01% 4463
2019
Q4
$297K Sell
8,899
-500
-5% -$16.7K ﹤0.01% 4609
2019
Q3
$223K Buy
9,399
+2,695
+40% +$63.9K ﹤0.01% 4828
2019
Q2
$241K Sell
6,704
-12,720
-65% -$457K ﹤0.01% 4796
2019
Q1
$717K Buy
19,424
+17,553
+938% +$648K ﹤0.01% 4113
2018
Q4
$81K Buy
1,871
+814
+77% +$35.2K ﹤0.01% 5275
2018
Q3
$50K Hold
1,057
﹤0.01% 5480
2018
Q2
$53K Buy
+1,057
New +$53K ﹤0.01% 5386